Evidence map›Paper›PMID 42365368›Full record

Observational studyCritical care (London, England)2026

Association between red blood cell transfusion volume and infection risk: a dose-response analysis of a nationwide trauma registry.

Teppei Ogawa, Takashi Hongo, Shodai Yoshihiro, Tsuyoshi Nojima, Kohei Tokioka, Tomohiro Hiraoka, Yoshinori Ueda, Ippei Matsuo, Takafumi Obara, Hiromichi Naito and 2 more

Abstract readObservational Study
In one paragraph

Observational study in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Teppei OgawaDentistry, and Pharmaceutical Sciences, Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Faculty of Medicine, 2-5-1 Shikata, Kita, 700-8558, Okayama, Japan.
Takashi HongoDentistry, and Pharmaceutical Sciences, Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Faculty of Medicine, 2-5-1 Shikata, Kita, 700-8558, Okayama, Japan. taka.hongo123@gmail.com.
Shodai YoshihiroDepartment of Pharmaceutical Services, Hiroshima University Hospital, Kasumi 1-2-3, Minami-ku, Hiroshima, 734-8551, Japan.
Tsuyoshi NojimaDentistry, and Pharmaceutical Sciences, Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Faculty of Medicine, 2-5-1 Shikata, Kita, 700-8558, Okayama, Japan.
Kohei TokiokaDentistry, and Pharmaceutical Sciences, Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Faculty of Medicine, 2-5-1 Shikata, Kita, 700-8558, Okayama, Japan.
Tomohiro HiraokaDentistry, and Pharmaceutical Sciences, Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Faculty of Medicine, 2-5-1 Shikata, Kita, 700-8558, Okayama, Japan.
Yoshinori UedaDentistry, and Pharmaceutical Sciences, Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Faculty of Medicine, 2-5-1 Shikata, Kita, 700-8558, Okayama, Japan.
Ippei MatsuoDentistry, and Pharmaceutical Sciences, Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Faculty of Medicine, 2-5-1 Shikata, Kita, 700-8558, Okayama, Japan.
Takafumi ObaraDentistry, and Pharmaceutical Sciences, Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Faculty of Medicine, 2-5-1 Shikata, Kita, 700-8558, Okayama, Japan.
Hiromichi NaitoDentistry, and Pharmaceutical Sciences, Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Faculty of Medicine, 2-5-1 Shikata, Kita, 700-8558, Okayama, Japan.
Atsunori NakaoDentistry, and Pharmaceutical Sciences, Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Faculty of Medicine, 2-5-1 Shikata, Kita, 700-8558, Okayama, Japan.
Tetsuya YumotoDentistry, and Pharmaceutical Sciences, Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Faculty of Medicine, 2-5-1 Shikata, Kita, 700-8558, Okayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfection is a major complication after trauma and is associated with worse clinical outcomes. Although red blood cell (RBC) transfusion is an essential component of resuscitation in trauma patients, its relationship with infection risk remains controversial. Furthermore, the dose-response relationship has not been fully elucidated.

methodsWe conducted a retrospective observational study using a nationwide trauma registry in Japan. Trauma patients registered between 2019 and 2021 were included. Patients were categorized into four groups according to RBC transfusion volume within the first 24 h after admission: None (0 units), Low (1-4 units), Moderate (5-9 units), and High (≥ 10 units). The primary outcome was in-hospital infection. Multivariable modified Poisson regression analyses were performed to estimate adjusted risk ratios (RRs) with 95% confidence intervals (CIs). Furthermore, we performed multivariable-adjusted restricted cubic spline analyses with four knots to assess the adjusted dose-response relationship between RBC transfusion volume and the risk of in-hospital infection.

resultsA total of 55,807 patients were analyzed. The incidence of in-hospital infection increased across transfusion categories: 4,399/48,308 (9.1%) in the None group, 618/3,724 (16.6%) in the Low group, 396/1,733 (22.8%) in the Moderate group, and 548/2,042 (26.8%) in the High group. In multivariable analysis, compared with the None group, Low (adjusted RR 1.85, 95% CI 1.62-2.10), Moderate (adjusted RR 1.95, 95% CI 1.69-2.26) and High (adjusted RR 2.07, 95% CI 1.76-2.43) transfusion volumes were associated with significantly increased risks of infection, respectively. Restricted cubic spline analyses showed an increase in infection risk at lower transfusion volumes, followed by a plateau at higher transfusion volumes.

conclusionsRBC transfusion volume within the first 24 h after trauma was associated with in-hospital infection risk. The association was generally linear at lower transfusion volumes, whereas a plateau was observed at higher transfusion volumes. Given the observational nature of this study, these findings should be interpreted cautiously.

Indexed as

Erythrocyte TransfusionAdultAgedFemaleHumansIncidenceJapanMaleMiddle AgedRegistriesRetrospective StudiesRisk FactorsWounds and InjuriesInfectionRed blood cellSepsisTransfusion

Identifiers

PMID42365368
PMCPMC13573453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.